EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential

Autumn M Matthews iD, Alexandra M Whiteley iD

Biochemical Society Transactions · 2025

DOI: 10.1042/bst20253053 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2025. Verfasst von Autumn M Matthews und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado, 80309, U.S.A. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Neurodegenerative Diseases, Cell Cycle Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquilins (UBQLNs) regulate cellular protein turnover by shuttling proteins, or ‘clients’, to the proteasome or autophagy pathways for degradation. Of the five different UBQLN genes in humans, UBQLN2 is the most highly expressed in the nervous system and muscle tissue and has been linked to multiple neurodegenerative diseases. In particular, point mutations of UBQLN2 cause an X-linked, dominant form of amyotrophic lateral sclerosis (ALS), ALS with frontotemporal dementia (ALS/FTD), or FTD. Failed protein degradation is a hallmark of many neurodegenerative diseases, including ALS and FTD; however, it is not clear exactly how ALS/FTD-associated UBQLN2 mutations contribute to pathogenesis. Recent studies have revealed the complexity of UBQLN2 biology and allow deeper understanding as to how UBQLN2 dysfunction may contribute to neurodegenerative disease. UBQLN2 is necessary for mitochondrial protein degradation and for regulating mitochondrial turnover, both of which are essential for motor neurons and have been implicated in the pathogenesis of ALS. Stress granule (SG) formation and regulation are also affected by UBQLN2 mutations, and their dysregulation may contribute to the toxic protein aggregation and SG changes observed in neurodegenerative disease. Finally, there are compelling links connecting UBQLN2 dysfunction with changes to downstream neuronal morphology, function, and behavior. This review will detail the emerging consensus on how UBQLN2 protects against neurodegenerative disease and will provide insights into potential therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingNeurodegenerative DiseasesCell Cycle ProteinsHumansAutophagy-Related ProteinsAnimalsAmyotrophic Lateral SclerosisAutophagyMutationMitochondriaFrontotemporal Dementia

Stichwörter der Autor:innen

ALSPEG10Ubiquilin 2mitochondrianeurodegenerative diseaseprotein degradationstress granules

Substanzen

Autophagy-Related ProteinsUBQLN2 protein, humanAdaptor Proteins, Signal TransducingCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado, 80309, U.S.A.

ORCID-Profile: Autumn M Matthews, Alexandra M Whiteley

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Matthews, A. M., & Whiteley, A. M. (2025). UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential. Biochemical Society Transactions. https://doi.org/10.1042/bst20253053

Vancouver

Matthews AM, Whiteley AM. UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential. Biochemical Society Transactions. 2025. doi:10.1042/bst20253053

BibTeX
@article{Matthews2025,
  author = {Matthews, Autumn M and Whiteley, Alexandra M},
  title = {UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential},
  journal = {Biochemical Society Transactions},
  year = {2025},
  doi = {10.1042/bst20253053}
}
Kostenlos starten →